Biotech Archives - Page 97 of 795

2 minute read

What’s Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk’s Weight Loss Drug Wegovy

February 15, 10:05 AM

Rise of adolescent usage of Novo Nordisk's Wegovy for pediatric obesity. Surging demand among families, but concerns linger on the impact of weight-loss drugs on growing children's development.

LLY

1 minute read

HCA Healthcare Selects Teradata VantageCloud To Complement Data Strategy

By Benzinga Newsdesk

February 15, 10:04 AM

One of the nation's leading providers of healthcare services to migrate certain on-premises operational workloads to VantageCloud on Google CloudTeradata (NYSE:TDC) today announced that HCA Healthcare is moving certain

HCA

1 minute read

Lantern Pharma Advances ADC Program Across Multiple Solid Tumor Cancers

By Benzinga Newsdesk

February 15, 9:07 AM

Lantern, in collaboration with academic research partners, has advanced the development, synthesis, and preclinical proof-of-concept of a novel, highly potent, cryptophycin-based ADC.The cryptophycin ADC has shown

LTRN

5 minute read

Dyne Therapeutics Announces Upcoming Presentations On Initial Clinical Data From Its ACHIEVE Trial In DM1 Patients And DELIVER Trial In DMD Patients At The 2024 Muscular Dystrophy Association Clinical & Scientific Conference

By Benzinga Newsdesk

February 14, 6:09 PM

- Presentations will Highlight Initial Data Announced in January 2024 Demonstrating Proof-of-Concept in its DM1 and DMD Programs, Validating the Promise of the FORCE™ Platform and Targeted Delivery to Muscle

DYN

3 minute read

Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated As A Carrier Of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells In The Treatment Of Severe Ocular Surface Disease

By Happy Mohamed

February 14, 5:32 PM

-Highlights potential uses of Celularity biomaterials in regenerative medicine applications that combine stem cells and biomaterial scaffolds for use in constructing tissues and for cell delivery -Poster

CELU

2 minute read

Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says

By Vandana Singh

February 14, 4:11 PM

Biogen's Leqembi launch challenges impact stock growth; Spinraza faces competition. Analyst lowers price target to $316, citing uncertainties.

BIIB

2 minute read

Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg’s Opinion Piece

By Vandana Singh

February 14, 1:51 PM

Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence.

RENB

2 minute read

Cardiology’s Quantum Leap: FDA’s Advisory Panel Gives Thumbs Up To Abbott’s Minimally Invasive Heart Valve Repair Device

By Vandana Singh

February 14, 1:47 PM

FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.

ABT

2 minute read

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia’s Weed Industry Goes Global

By Nicolas Jose Rodriguez

February 14, 12:21 PM

Clever Leaves Holdings Inc.

AVCNF

1 minute read

What’s Going On With Eli Lilly Stock Wednesday?

By Vandana Singh

February 14, 11:35 AM

Eli Lilly's shares surge 25% YTD to $700 billion enterprise value. Mounjaro and Zepbound drive growth with tirzepatide. BMO Capital projects $12.78 billion FY2024 tirzepatide revenues.

LLY